EN DE

Hancom Lifecare Inc. (372910) Fair Value & Analysis

Technology · KR · Market cap 46.9B KRW

HL Hancom Lifecare Inc. 372910 · KO
Price1,799 KRW
Fair Value1,900 KRW
Upside+5.6%
Quality56/100
Watch Hancom Lifecare Inc. for free, get notified when fair value or trend changes. Watch for free

Strengths

Low debt · generates free cash flow

Risks

!Weak Growth
!Loss-making · -7.8% net margin
!Mixed vs. peers (4/9)
!Narrow moat 11/100
Weak Growth
Loss-making · -7.8% net margin
Low debt · generates free cash flow
Mixed vs. peers (4/9)
Narrow moat 11/100
Evidence: Medium Range 1,229 KRW – 2,571 KRW Share as image

Fair value as of: Aug 13, 2026

From 10 valuation models · updated 9 days ago

Fair value updated Aug 13, 2026, revised from 1,155 KRW to 1,900 KRW (+64.6%) since Jul 22, 2026. Share price +9.2% over the past month.

A solid business, currently priced close to our fair value.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • A fairly wide model range (1,229 KRW to 2,571 KRW) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

13,350 KRW 1,608 KRW Fair Value 1,900 KRW Aug 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range 1,608 KRW – 13,350 KRW · fair‑value band 1,229 KRW – 2,571 KRW · the 1,799 KRW price screens below the 1,900 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Hancom Lifecare Inc. (372910) currently trades at 1,799 KRW, while our model-based Fair Value estimate is 1,900 KRW, implying the stock looks roughly 5.6% fairly valued today. The Quality Score stands at 56/100 (solid quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, Hancom Lifecare Inc. generated revenue of 91.4B KRW at a net margin of -7.8%. Revenue declined 9.9% year over year. It earns a return on equity of -5.5%. Net debt stands at 21.7B KRW. Fundamentals as of Aug 13, 2026

Our scenario range runs from 1,229 KRW (bear case) to 2,571 KRW (bull case); at 1,799 KRW, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 52% below its 52-week high, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -42% fair-value upside, at 6%, 372910 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 8,002 KRW 10,243 KRW 14,078 KRW 80
Rev-Margin DCF 7,216 KRW 9,781 KRW 12,930 KRW 74
EV/EBITDA 3,859 KRW 4,530 KRW 5,201 KRW 54
All 10 models by family
DCF Models
FCF DCF 7,728 KRW 10,037 KRW 14,315 KRW 38
5Y Revenue Exit 7,216 KRW 9,643 KRW 13,169 KRW 39
5Y EBITDA Exit 5,170 KRW 6,101 KRW 7,336 KRW 41
10Y Revenue Exit 7,226 KRW 9,054 KRW 11,010 KRW 36
10Y EBITDA Exit 6,129 KRW 6,864 KRW 7,586 KRW 37
Multiples
EV/EBITDA 3,859 KRW 4,530 KRW 5,201 KRW 54
EV/Revenue 7,354 KRW 9,715 KRW 12,075 KRW 43
Asset-Based
NCAV (Graham) 2,295 KRW 3,075 KRW 4,590 KRW 50
Growth DCF
Growth DCF 8,002 KRW 10,243 KRW 14,078 KRW 80
Rev-Margin DCF 7,216 KRW 9,781 KRW 12,930 KRW 74

Widest divergence: Growth DCF (9,781 KRW) versus Asset-Based (3,075 KRW). Highest evidence: Growth DCF (80).

Notify me when 372910 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 91.4B KRW
Revenue growth (YoY) -9.9%
Net margin -7.8%
Return on equity -5.5%
Free cash flow 16.8B KRW FY2025
Operating margin -63.7%
More key figures
EPS growth (YoY) -98.1%
Net debt 21.7B KRW FY2020

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 56/100

Of which business quality 59 · Market factors (momentum, volatility) 24

Profitability 10
Margins and returns on capital today
Quality Growth 23
Are margins and returns improving?
Cashflow 76
Earnings quality: real cash, not paper profit
Fin. Strength 83
Balance sheet, leverage, solvency risk
Investment 92
Disciplined investing over empire-building
Low Volatility 67
Calm price path (market factor)
Momentum 7
Price trend over the last 3–12 months (market factor)
52W Momentum 5
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

HANCOM LIFECARE Inc. manufactures and sells personal safety equipment in South Korea, Vietnam, Mongolia, Indonesia, Thailand, the Philippines, and the Middle East countries.

Full company description

HANCOM LIFECARE Inc. manufactures and sells personal safety equipment in South Korea, Vietnam, Mongolia, Indonesia, Thailand, the Philippines, and the Middle East countries. The company offers air respirators, marine air respirators, breathing masks, and portable respirators; firefighting suits, helmets, boots, gloves, thermal suits, fire blankets, and tactical armor; as well as gas detection, and fire disaster safety kits. Its products are used in military, fire, and industrial markets, as well as the smart city public safety field. The company was founded in 1971 and is headquartered in Yongin-si, South Korea.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Hancom Lifecare Inc. reported revenue of 92.1B KRW in FY2025 versus 121B KRW in FY2021, a compound −6.6%/yr. Reported net income was −7.7B KRW in FY2025.

Growth Quality 23/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
92.1B KRW
Latest YoY
−12.1%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−2.7%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−9.5%
Avg. growth/yr (6Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.6%
Revenue −6.6%/yr
FY21 121B KRW
FY22 100B KRW
FY23 113B KRW
FY24 105B KRW
FY25 92.1B KRW
Net income
FY21 4.8B KRW
FY22 9.2B KRW
FY23 825M KRW
FY24 7.4B KRW
FY25 −7.7B KRW

Watch 372910: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Hancom Lifecare Inc. Fair Value". https://www.fairvalue-calculator.com/stock/372910

Peer Group

Software - Application · 728 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 56 · Above median
Fair Value upside +6% · Above median
Return on assets -2% · Below median
Net margin (TTM) -8% · Bottom 25%
Operating margin (TTM) -64% · Bottom 25%
Revenue growth -10% · Bottom 25%
Debt / equity 0.00× · Lower than median

Valuation Multiples vs Software - Application median · lower = cheaper

P/FCF 0.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE41 · sector 0
FUTURE0 · sector 39
PAST0 · sector 12
HEALTH100 · sector 98
DIVIDEND0 · sector 29

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Software - Application stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
SAP SE SAPS C$12.46 C$16.26 +30%
Shopify Inc SHOP C$209.78 C$28.76 -86%
Uber Technologies, Inc UBER $75.36 $43.66 -42%
Salesforce, Inc CRM $193.32 $249.28 +29%
ServiceNow, Inc NOW $124.94 $43.73 -65%
Cadence Design Systems, Inc CDNS $323.13 $112.57 -65%
Tata Elxsi Limited TATAELXSI ₹3,712 ₹2,519 -32%
Douzone Bizon Co 012510 120,000 KRW 92,181 KRW -23%
KFin Technologies Limited KFINTECH ₹962.00 ₹554.07 -42%
RateGain Travel Technologies Limited RATEGAIN ₹988.60 ₹449.85 -54%

Compare Hancom Lifecare Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Evidence & backtest 34 years, survivorship-adjusted Financial calculators DCF, Graham, PEG and more

Frequently asked questions

Is Hancom Lifecare Inc. (372910) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of 1,900 KRW versus a price of 1,799 KRW, about +6% (fairly valued).
What is the fair value of 372910?
Our model-based fair value for Hancom Lifecare Inc. is 1,900 KRW (as of Aug 13, 2026), built from audited fundamentals. The current price: 1,799 KRW.
What is the quality score of 372910?
Hancom Lifecare Inc. has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Hancom Lifecare Inc. (372910)?
Hancom Lifecare Inc. reported trailing-twelve-month revenue of about 91.4B KRW (latest available figure, as of Aug 13, 2026).
What is the net profit margin of 372910?
The net profit margin of Hancom Lifecare Inc. is about -7.8%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Hancom Lifecare Inc. and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.